Key regions: United Kingdom, Canada, Japan, Europe, China
The demand for dermatological drugs in Germany has been growing at a steady pace in recent years.
Customer preferences: Customers in Germany have shown a preference for natural and organic ingredients in their skincare products. This has led to an increase in the demand for dermatological drugs that contain natural ingredients. Additionally, there is a growing demand for products that are free from chemicals and are environmentally friendly.
Trends in the market: The dermatological drugs market in Germany has been witnessing a trend towards personalized skincare. Customers are increasingly looking for products that are tailored to their specific needs and preferences. This has led to the development of customized skincare products that are designed to address individual skin concerns.Another trend in the market is the growing popularity of anti-aging products. As the population in Germany ages, there is a greater demand for products that can help to reduce the signs of aging and improve skin elasticity.
Local special circumstances: Germany has a strong tradition of using natural remedies and herbal medicines for skincare. This has led to the development of a number of natural and herbal-based dermatological drugs in the market. Additionally, there is a high level of awareness among consumers about the potential side effects of chemicals in skincare products. As a result, there is a growing demand for products that are free from harmful chemicals.
Underlying macroeconomic factors: The German economy has been performing well in recent years, with a strong focus on innovation and research. This has led to the development of new and innovative skincare products in the market. Additionally, the aging population in Germany has led to an increase in demand for skincare products, including dermatological drugs. The healthcare sector in Germany is also highly regulated, which ensures that products in the market are safe and effective.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
